Yew Bio-Pharm Group
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Yew Bio-Pharm Group's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2% to $27,307,687. The net income raised on $1,464,882 and profit margin reached 5%. Total operating expenses were $988,974.

Profit Margin

Yew Bio-Pharm Group, Inc. (OTC:YEWB): Profit margin
2012 6.72M 2.20M 32.79%
2013 7.43M 3.89M 52.42%
2014 7.72M 4.28M 55.45%
2015 29.57M 5.28M 17.87%
2016 51.34M 2.00M 3.91%
2017 40.53M 3.21M 7.93%
2018 37.59M -1.32M -3.52%
2019 27.88M 985.50K 3.53%
2020 27.30M 1.46M 5.36%

YEWB Income Statement (2012 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
27.30M27.88M37.59M40.53M51.34M29.57M7.72M7.43M6.72M
Cost of revenue
23.78M27.10M26.87M35.47M48.11M22.54M2.13M2.40M1.27M
Gross profit
3.52M774.13K10.72M5.06M3.23M7.03M5.58M5.03M5.44M
Operating exp.
Research and development
000059135300
Selling and marketing
003186.63K34.82K28.62K21.52K23.79K24.60K
Total operating expenses
988.97K1.45M2.08M1.73M1.11M1.89M1.30M1.13M3.24M
Operating income
2.56M-619.50K718.59K3.32M2.12M5.13M4.28M3.89M2.20M
Other income (expenses), net
-1.07M1.61M-8.17M-111.00K44.38K161.13K-1.77K1.34K1.76K
Income before tax
1.49M996.72K170.74K3.21M2.02M5.30M4.28M3.89M2.20M
Income tax expense
28.76K11.21K1.49M61418.00K16.48K1.77K-1.99K0
Net income
1.46M985.50K-1.32M3.21M2.00M5.28M4.28M3.89M2.20M
Earnings per share
Basic EPS
0.030.02-0.020.060.040.10.080.080.05
Diluted EPS
0.030.02-0.020.060.040.10.070.080.05
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source